Table 1

Trial registration data

Data categoryInformation
Primary registry and trial identifying numberAustralian New Zealand Clinical Trials Registry (
Ref No. ACTRN12617000251325
Date of registration17 February 2017
Public titleComparing Home Infusion Devices for antibiotic treatment—CHID Study
Scientific titleA randomised crossover trial evaluating patient and nurse satisfaction of the electronic portable infusion device (ambIT Continuous) versus elastomeric delivery (Baxter Infusor) for the continuous administration of antibiotics in the home in patients with infectious disease
Trial acronymCHID
Health conditionsAny infectious disease requiring intravenous antibiotic therapy and suitable for treatment via a continuous infusion in the home setting
Study typeInterventional
Intervention codeTreatment: devices
Control treatmentTreatment administered via an elastomeric infusion pump
Key inclusion criteriaSuitable for ambulatory home antibiotic therapy as approved by infectious diseases specialist
Inpatient of Royal Adelaide Hospital
Can provide informed consent
Require 8 days minimum therapy
Able to provide feedback through questionnaire and logbook
18 years of age or older
Key exclusion criteriaPatient is unable or unwilling to fill out the patient questionnaire survey and or logbook
Skin allergy or contact dermatitis to stainless steel
Patient's primary clinician is unwilling to enrol patient
Patient is totally dependent on care for all daily needs and/or is immobile
The following antibiotics are excluded due to restricted shelf life: ceftazidime, ticarcillin/clavulanate
Recruitment stateSouth Australia
Recruitment hospitalThe Royal Adelaide Hospital—Adelaide
Funding source 1Government of South Australia, Department of Further Education, Employment, Science and Technology (now Department of State Development)
Funding source 2CPIE Pharmacy Services, Findon, South Australia
Primary sponsorFlinders University, Bedford Park, South Australia
Other collaboratorCPIE Pharmacy Services, Findon, South Australia
Ethics committeeRoyal Adelaide Hospital Human Research Ethics Committee, Approval No. R20160420